306 results on '"Higazi, Abd Al-Roof"'
Search Results
52. Could Intelligent Computers Postulate Their Own Evolution Theory Which Would Be More Plausible than that of the Humans?
53. tPA variant tPA-A296-299Prevents impairment of cerebral autoregulation and necrosis of hippocampal neurons after stroke by inhibiting upregulation of ET-1
54. Abstract WP285: tPA Variant tPA-A296-299 Prevents Impairment of Cerebral Autoregulation and Hippocampal Neuronal Necrosis After Stroke Through Inhibition of ET-1 Upregulation
55. Release of IL-6 After Stroke Contributes to Impaired Cerebral Autoregulation and Hippocampal Neuronal Necrosis Through NMDA Receptor Activation and Upregulation of ET-1 and JNK.
56. Tissue-Type Plasminogen Activator-A 296–299 Prevents Impairment of Cerebral Autoregulation After Stroke Through Lipoprotein-Related Receptor–Dependent Increase in cAMP and p38
57. Abstract 172: tPA Variant tPA-A296-299 Prevents Impairment of Cerebral Autoregulation After Stroke Through LRP Dependent Increase in cAMP and p38 MAPK
58. tPA variant tPA-A296-299 Prevents impairment of cerebral autoregulation and necrosis of hippocampal neurons after stroke by inhibiting upregulation of ET-1.
59. B-cell markers from the BAFF family as predictors for experimental autoimmune myasthenia gravis aggravation in mice lacking plasminogen activator components
60. tPA‐S481A prevents impairment of cerebrovascular autoregulation by endogenous tPA after traumatic brain injury by upregulating p38 MAPK and inhibiting ET‐1 (1068.13)
61. Neutrophil a-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability
62. PAI-1-Derived Peptide EEIIMD Prevents Hypoxia/Ischemia-Induced Aggravation of Endothelin- and Thromboxane-Induced Cerebrovasoconstriction
63. tPA-S481A Prevents Impairment of Cerebrovascular Autoregulation by Endogenous tPA after Traumatic Brain Injury by Upregulating p38 MAPK and Inhibiting ET-1
64. The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention
65. Contact with stroke
66. Combination therapy with glucagon and a novel plasminogen activator inhibitor-1-derived peptide enhances protection against impaired cerebrovasodilation during hypotension after traumatic brain injury through inhibition of ERK and JNK MAPK
67. tPA-S481A Prevents Neurotoxicity of Endogenous tPA in Traumatic Brain Injury
68. Abstract 2579: tPA Contributes To Aggravation of Endothelin and Thromboxane Induced Cerebrovasoconstriction After Hypoxia/Ischemia Through Upregulation of ERK MAPK
69. RBC-coupled tPA Prevents Whereas tPA Aggravates JNK MAPK-Mediated Impairment of ATP- and Ca-Sensitive K Channel-Mediated Cerebrovasodilation After Cerebral Photothrombosis
70. tPA contributes to impaired NMDA cerebrovasodilation after traumatic brain injury through activation of JNK MAPK
71. tPA regulates pulmonary vascular activity through NMDA receptors
72. Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate
73. Glucagon Protects Against Impaired NMDA-Mediated Cerebrovasodilation and Cerebral Autoregulation during Hypotension after Brain Injury by Activating cAMP Protein Kinase A and Inhibiting Upregulation of tPA
74. Neuroprotection by glucagon: role of gluconeogenesis
75. PAI‐1 derived peptide EEIIMD prevents impairment of hypercapnic and hypotensive cerebrovasodilation by augmenting p38 MAPK upregulation after cerebral hypoxia/ischemia
76. Inhibition of integrin aVB3 prevents uPA–mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia
77. Inhibition of integrin αVβ3prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia
78. uPA Modulates the Age-Dependent Effect of Brain Injury on Cerebral Hemodynamics through LRP and ERK MAPK
79. Urokinase Plasminogen Activator Impairs SNP and PGE2Cerebrovasodilation after Brain Injury through Activation of LRP and ERK MAPK
80. uPA Contributes To Impairment Of SNP and PGE2 Cerebrovasodilation After Brain Injury Through Activation of LRP and ERK MAPK
81. LRP and αvβ3mediate tPA activation of smooth muscle cells
82. Neutralizing the neurotoxic effects of exogenous and endogenous tPA
83. Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1–143)
84. Regulation of neovascularization by human neutrophil peptides (α‐defensins): a link between inflammation and angiogenesis
85. The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation
86. Tissue-Type Plasminogen Activator-A296–299Prevents Impairment of Cerebral Autoregulation After Stroke Through Lipoprotein-Related Receptor–Dependent Increase in cAMP and p38
87. Urokinase‐derived peptides regulate vascular smooth muscle contractionin vitroandin vivo
88. A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell deathin vivo
89. Lysis of Plasma Clots by Urokinase-Soluble Urokinase Receptor Complexes
90. Tissue Factor Regulates Plasminogen Binding and Activation
91. Regulation of Single Chain Urokinase Binding, Internalization, and Degradation by a Plasminogen Activator Inhibitor 1-Derived Peptide
92. Defensin Stimulates the Binding of Lipoprotein (a) to Human Vascular Endothelial and Smooth Muscle Cells
93. Soluble Human Urokinase Receptor Is Composed of Two Active Units
94. Commentary on: ‘Effect of purified soluble urokinase receptor on the plasminogen prourokinase activation system’ by N. Behrendt and K. Dano, FEBS Letters, 393 (1996) 31–36
95. REGULATION OF SINGLE CHAIN UROKINASE BY SMALL PEPTIDES
96. Defensin Modulates Tissue-type Plasminogen Activator and Plasminogen Binding to Fibrin and Endothelial Cells
97. Inhibition of plasminogen activation by triiodothyronine
98. Enhancement of the Enzymatic Activity of Single-chain Urokinase Plasminogen Activator by Soluble Urokinase Receptor
99. Identification of an Inhibitor of Tissue-type Plasminogen Activator-mediated Fibrinolysis in Human Neutrophils
100. Regulation of neutrophil activation by oleic acid
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.